Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway

Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway

AimHeart failure (HF) post-acute myocardial infarction (AMI) leads to a large number of hospitalizations and deaths worldwide. Danqi pill (DQP) is included in the 2015 national pharmacopoeia and widely applied in the treatment of HF in clinics in China. We examined whether DQP acted on glucose metab...

Full description

Bibliographic Details
Main Authors: Qian Zhang, Dongqing Guo, Yuanyuan Wang, Xiaoping Wang, Qiyan Wang, Yan Wu, Chun Li, Wei Wang, Yong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Pharmacology
Subjects:
Danqi Pill (DQP)
heart failure (HF)
acute myocardial infarction (AMI)
glucose metabolism
HIF-1α/PGC-1α pathway
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00458/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00458/full

Similar Items